Design enzyme inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Kidney Kidney Glomerulus Endothelium, Vascular Myocardium Heart Sympathetic Nervous System Aorta

Organisms8

Rats, Inbred SHR Rats, Inbred WKY Rats, Wistar Rats, Sprague-Dawley Dogs Digitalis Rats, Inbred Strains Rabbits

Diseases40

Hypertension Angioedema Heart Failure Proteinuria Hyperkalemia Hypertension, Renal Diabetic Nephropathies Kidney Diseases Kidney Failure, Chronic Albuminuria Hypertension, Renovascular Myocardial Infarction Chronic Disease Cardiac Output, Low Oligohydramnios Cough Ventricular Dysfunction, Left Cardiovascular Diseases Hypertrophy, Left Ventricular Diabetes Mellitus, Type 2 Disease Progression Hypotension Body Weight Disease Models, Animal Diabetes Mellitus Renal Insufficiency Nephrotic Syndrome Acute Kidney Injury Hypertension, Malignant Fibrosis Diabetes Complications Cardiomyopathy, Dilated Coronary Artery Disease Glomerulonephritis, IGA Myocardial Ischemia Ventricular Remodeling Bronchial Spasm Cardiomegaly Glomerulosclerosis, Focal Segmental Renal Artery Obstruction

Chemicals and Drugs109

Angiotensin-Converting Enzyme Inhibitors Enalapril Captopril Lisinopril Angiotensin Receptor Antagonists Perindopril Enalaprilat Antihypertensive Agents Ramipril Angiotensin II Type 1 Receptor Blockers Cilazapril Enzyme Inhibitors Teprotide Thiazepines Tetrazoles Renin Diuretics Adrenergic beta-Antagonists Imidazolidines Tetrahydroisoquinolines Losartan 3-Mercaptopropionic Acid Angiotensin II Bradykinin Peptidyl-Dipeptidase A Kinins Biphenyl Compounds Angiotensin I Fosinopril Saralasin Calcium Channel Blockers Receptors, Bradykinin Angiotensins Imidazoles Benzimidazoles Aldosterone Sodium Chloride Symporter Inhibitors Cardiovascular Agents Hydrochlorothiazide Hydralazine Indoles Receptor, Angiotensin, Type 1 Benzazepines Receptors, Angiotensin Mineralocorticoid Receptor Antagonists Amlodipine Proline Creatinine Spironolactone Dipeptides Hydroxymethylglutaryl-CoA Reductase Inhibitors Mopidamol Receptor, Bradykinin B2 Oligopeptides Valine Protease Inhibitors Fumarates Isoquinolines Phenylmethylsulfonyl Fluoride Angiotensinogen Receptor, Angiotensin, Type 2 Receptor, Bradykinin B1 Cyclohexanones Aspirin Digoxin Doxazosin Angiotensin II Type 2 Receptor Blockers Atenolol Neprilysin Cardiotonic Agents Aminopeptidases Bicyclo Compounds Furosemide Benzoates Endothelins Indapamide Biological Markers Pyridazines Amides RNA, Messenger Cyclooxygenase Inhibitors Endothelin-1 Sulfinpyrazone Benzothiadiazines Kallikreins Thiorphan Sodium, Dietary Norepinephrine Indolizines Blood Glucose Nitric Oxide Receptors, Endothelin Vasodilator Agents Felodipine Anti-Inflammatory Agents, Non-Steroidal Metalloendopeptidases Metoprolol Sodium Pyridines Placebos Atrial Natriuretic Factor Aspartic Acid Endopeptidases Glycopeptides Dihydralazine Thiazolidines NG-Nitroarginine Methyl Ester Indomethacin Carbazoles Nifedipine

Analytical, Diagnostic and Therapeutic Techniques and Equipment55

Drug Design Blood Pressure Research Design Drug Therapy, Combination Treatment Outcome Double-Blind Method Equipment Design Prospective Studies Risk Factors Retrospective Studies Randomized Controlled Trials as Topic Follow-Up Studies Glomerular Filtration Rate Cross-Over Studies Heart Rate Cohort Studies Nephrectomy Analysis of Variance Cross-Sectional Studies Organ Size Severity of Illness Index Clinical Trials as Topic Risk Assessment Diet, Sodium-Restricted Kidney Function Tests Random Allocation Body Weight Disease Models, Animal Multivariate Analysis Prognosis Single-Blind Method Prosthesis Design Regression Analysis Stroke Volume Hospitalization Models, Molecular Drug Administration Schedule Administration, Oral Logistic Models Drug Prescriptions Case-Control Studies Incidence Registries Drug Evaluation, Preclinical Renal Dialysis Prevalence Longitudinal Studies Reproducibility of Results Placebos Reference Values Patient Discharge Echocardiography Chi-Square Distribution Epidemiologic Research Design Predictive Value of Tests

Psychiatry and Psychology1

Patient Compliance

Phenomena and Processes27

Renin-Angiotensin System Blood Pressure Time Factors Dose-Response Relationship, Drug Hemodynamics Glomerular Filtration Rate Heart Rate Renal Circulation Ventricular Function, Left Organ Size Drug Interactions Diet, Sodium-Restricted Body Weight Systole Vascular Resistance Stroke Volume Molecular Structure Vasodilation Drug Synergism Kinetics Structure-Activity Relationship Algorithms Ventricular Remodeling Drinking Chi-Square Distribution Amino Acid Sequence Fermentation

Disciplines and Occupations4

Drug Design Research Design Evidence-Based Medicine Cardiology

Information Science8

Computer-Aided Design Software Design Incidence Registries Prevalence Algorithms Molecular Sequence Data Amino Acid Sequence

Health Care42

Treatment Outcome Double-Blind Method Prospective Studies Risk Factors Retrospective Studies Randomized Controlled Trials as Topic Follow-Up Studies Cross-Over Studies Cohort Studies Practice Guidelines as Topic Drug Utilization Review Secondary Prevention Guideline Adherence Analysis of Variance Cross-Sectional Studies Drug Utilization Severity of Illness Index Clinical Trials as Topic Risk Assessment Random Allocation Multivariate Analysis Single-Blind Method Regression Analysis Hospitalization Age Factors Logistic Models Drug Prescriptions Case-Control Studies Incidence Fees, Pharmaceutical Registries Patient Compliance Prevalence Longitudinal Studies Reproducibility of Results Physician's Practice Patterns Patient Discharge Chi-Square Distribution Epidemiologic Research Design Sex Factors Predictive Value of Tests Comorbidity

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care Geographicals

Angiotensin-Converting Enzyme Inhibitors Enalapril Captopril Lisinopril Angiotensin Receptor Antagonists Perindopril Enalaprilat Antihypertensive Agents Ramipril Angiotensin II Type 1 Receptor Blockers Cilazapril Enzyme Inhibitors Teprotide Renin-Angiotensin System Hypertension Drug Design Blood Pressure Research Design Thiazepines Tetrazoles Renin Diuretics Adrenergic beta-Antagonists Imidazolidines Tetrahydroisoquinolines Angioedema Losartan 3-Mercaptopropionic Acid Heart Failure Angiotensin II Bradykinin Drug Therapy, Combination Peptidyl-Dipeptidase A Kinins Proteinuria Biphenyl Compounds Angiotensin I Fosinopril Treatment Outcome Rats, Inbred SHR Time Factors Saralasin Hyperkalemia Kidney Calcium Channel Blockers Receptors, Bradykinin Angiotensins Double-Blind Method Imidazoles Equipment Design Benzimidazoles Dose-Response Relationship, Drug Aldosterone Sodium Chloride Symporter Inhibitors Cardiovascular Agents Hydrochlorothiazide Prospective Studies Hydralazine Hypertension, Renal Indoles Receptor, Angiotensin, Type 1 Computer-Aided Design Risk Factors Retrospective Studies Benzazepines Diabetic Nephropathies Hemodynamics Kidney Diseases Kidney Failure, Chronic Receptors, Angiotensin Randomized Controlled Trials as Topic Follow-Up Studies Mineralocorticoid Receptor Antagonists Rats, Inbred WKY Amlodipine Proline Glomerular Filtration Rate Cross-Over Studies Creatinine Spironolactone Albuminuria Dipeptides Hydroxymethylglutaryl-CoA Reductase Inhibitors Hypertension, Renovascular Mopidamol Myocardial Infarction Receptor, Bradykinin B2 Chronic Disease Oligopeptides Heart Rate Cardiac Output, Low Valine Protease Inhibitors Cohort Studies United States Oligohydramnios Cough Fumarates Rats, Wistar Practice Guidelines as Topic

No FAQ available that match "design enzyme inhibitors"